107 related articles for article (PubMed ID: 29273425)
1. Supercharged green fluorescent protein delivers HPV16E7 DNA and protein into mammalian cells in vitro and in vivo.
Motevalli F; Bolhassani A; Hesami S; Shahbazi S
Immunol Lett; 2018 Feb; 194():29-39. PubMed ID: 29273425
[TBL] [Abstract][Full Text] [Related]
2. Anti-viral Effects of Superpositively Charged Mutant of Green Fluorescent Protein.
Vahabpour R; Basimi P; Roohvand F; Asadi H; Irani GM; Zabihollahi R; Bolhassani A
Protein Pept Lett; 2019; 26(12):930-939. PubMed ID: 31441722
[TBL] [Abstract][Full Text] [Related]
3. Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response.
Mardani G; Bolhassani A; Agi E; Shahbazi S; Mehdi Sadat S
IUBMB Life; 2016 Jun; 68(6):459-67. PubMed ID: 27094221
[TBL] [Abstract][Full Text] [Related]
4. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
Shahbazi S; Bolhassani A
Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237
[TBL] [Abstract][Full Text] [Related]
5. Delivery of molecular cargoes in normal and cancer cell lines using non-viral delivery systems.
Shahbazi S; Haghighipour N; Soleymani S; Nadji SA; Bolhassani A
Biotechnol Lett; 2018 Jun; 40(6):923-931. PubMed ID: 29633093
[TBL] [Abstract][Full Text] [Related]
6. Generation of the Fluorescent HPV16 E7 Protein for Detection of Delivery In vitro.
Shahbazi S; Bolhassani A; Arashkia A; Sadroddiny E
Protein Pept Lett; 2018; 25(3):244-252. PubMed ID: 29336241
[TBL] [Abstract][Full Text] [Related]
7. MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
Saleh T; Bolhassani A; Shojaosadati SA; Aghasadeghi MR
Vaccine; 2015 Jun; 33(28):3164-70. PubMed ID: 26001433
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.
Salehi M; Taheri T; Mohit E; Zahedifard F; Seyed N; Taslimi Y; Sattari M; Bolhassani A; Rafati S
Immunotherapy; 2012 Nov; 4(11):1107-20. PubMed ID: 23194361
[TBL] [Abstract][Full Text] [Related]
9. In vitro expression of HPV16 E7 linked to HMGB1 immunoadjuvant in mammalian cells.
Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
Bratisl Lek Listy; 2016; 117(10):609-613. PubMed ID: 27826978
[TBL] [Abstract][Full Text] [Related]
10. Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
Wang Z; Wei C; Zhang Y; Wang W; Zhou Z; Xiao G
Oncol Rep; 2018 Jan; 39(1):425-432. PubMed ID: 29115562
[TBL] [Abstract][Full Text] [Related]
11. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
[TBL] [Abstract][Full Text] [Related]
12. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.
Zhou L; Zhu T; Ye X; Yang L; Wang B; Liang X; Lu L; Tsao YP; Chen SL; Li J; Xiao X
Hum Gene Ther; 2010 Jan; 21(1):109-19. PubMed ID: 19715402
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.
Mohit E; Bolhassani A; Zahedifard F; Seyed N; Eslamifar A; Taghikhani M; Samimi-Rad K; Rafati S
Mol Immunol; 2013 Jan; 53(1-2):149-60. PubMed ID: 22926003
[TBL] [Abstract][Full Text] [Related]
14. Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development.
Di Bonito P; Petrone L; Casini G; Francolini I; Ammendolia MG; Accardi L; Piozzi A; D'Ilario L; Martinelli A
Int J Nanomedicine; 2015; 10():3447-58. PubMed ID: 26056443
[TBL] [Abstract][Full Text] [Related]
15. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
[TBL] [Abstract][Full Text] [Related]
16. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
Mohit E; Bolhassani A; Zahedifard F; Taslimi Y; Rafati S
Scand J Immunol; 2012 Jan; 75(1):27-37. PubMed ID: 21916914
[TBL] [Abstract][Full Text] [Related]
17. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH
Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571
[TBL] [Abstract][Full Text] [Related]
18. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells.
Tahamtan A; Tabarraei A; Moradi A; Dinarvand M; Kelishadi M; Ghaemi A; Atyabi F
Artif Cells Nanomed Biotechnol; 2015; 43(6):366-72. PubMed ID: 24641772
[TBL] [Abstract][Full Text] [Related]
20. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
